TWD 10.0
(1.01%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 114.17 Million TWD | -27.74% |
2022 | 158 Million TWD | -7.39% |
2021 | 170.6 Million TWD | -0.51% |
2020 | 171.48 Million TWD | -4.73% |
2019 | 180 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 109.45 Million TWD | -4.04% |
2024 Q2 | 109.45 Million TWD | -0.07% |
2023 FY | 114.17 Million TWD | -27.74% |
2023 Q2 | 152 Million TWD | 0.0% |
2023 Q1 | 152 Million TWD | -3.8% |
2023 Q3 | 114.17 Million TWD | -24.89% |
2023 Q4 | 114.17 Million TWD | 0.0% |
2022 Q3 | 158 Million TWD | 0.0% |
2022 Q4 | 158 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | -88.243% |
Level Biotechnology Inc. | 9.88 Million TWD | -1055.013% |
Sagittarius Life Science Corp | 6.25 Million TWD | -1725.6% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | -239.276% |
TaiMed Biologics Inc. | 521.7 Million TWD | 78.115% |
GlycoNex Incorporation | - TWD | -Infinity% |
VBI | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | -16.811% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | -31.399% |
Mycenax Biotech Inc. | 569.78 Million TWD | 79.962% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 21.138% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -8723.261% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 55.113% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -24089.195% |
Enimmune corporation | 1.75 Million TWD | -6390.79% |
TaiRx, Inc. | 8.96 Million TWD | -1172.974% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 436.54 Million TWD | 73.846% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | -121.984% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 69.659% |
Lin BioScience, Inc. | 29.02 Million TWD | -293.347% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -1109.332% |
Feng Chi Biotech Corp. | 8.14 Million TWD | -1301.068% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | -7.508% |
Lukas Biomedical Inc. | 69.9 Million TWD | -63.326% |
RBC Bioscience Corporation | 412.59 Million TWD | 72.328% |
BiOptic Inc. | 85.79 Million TWD | -33.081% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -105615.741% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -949.288% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 70.427% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 48.627% |
Neith Corporation | 714 Thousand TWD | -15890.616% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 25.83 Million TWD | -341.897% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 68.806% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | -418.403% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | -104.183% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -1306.591% |
AP Biosciences Inc | 70.42 Million TWD | -62.115% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 74.577% |
3D Global Biotech Inc. | 4.08 Million TWD | -2696.987% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 3.582% |
Intech Biopharm Corporation | 970.4 Million TWD | 88.235% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 71.31% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -7009.153% |
TWi Biotechnology, Inc. | 5.6 Million TWD | -1937.712% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -22598.41% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -1928.66% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | -3373.471% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 54.424% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -3396.876% |
PharmaEngine, Inc. | 7.14 Million TWD | -1498.39% |
Savior Lifetec Corporation | 257.03 Million TWD | 55.581% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | -94.469% |
OBI Pharma, Inc. | 439.88 Million TWD | 74.045% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | -670.866% |
Acepodia, Inc. | 233.45 Million TWD | 51.093% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | -861.538% |